Biosynex SA (ALBIO) Financial Statements
Biosynex SA Financial Overview
Biosynex SA's market cap is currently $15.21M. The company's EPS TTM is $-4.26; its P/E ratio is -1.15; and it has a dividend yield of 13.15%. Biosynex SA is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 95.20M | $ 101.20M | $ 92.98M | $ 196.59M | $ 382.53M |
| Gross Profit | $ -3.60M | $ -20.00M | $ 49.13M | $ 64.52M | $ 182.55M |
| Operating Income | $ -4.70M | $ -21.10M | $ -37.40M | $ 38.86M | $ 140.65M |
| EBITDA | $ 8.50M | $ -2.67M | $ -10.18M | $ 51.73M | $ 142.01M |
| Net Income | $ -58.20M | $ -43.30M | $ -36.95M | $ 15.66M | $ 104.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.46M | $ 9.69M | $ 26.16M | $ 87.17M | $ 132.03M |
| Total Assets | $ 136.24M | $ 194.69M | $ 241.73M | $ 259.98M | $ 268.94M |
| Total Debt | $ 61.65M | $ 62.46M | $ 65.60M | $ 52.07M | $ 35.31M |
| Net Debt | $ 53.19M | $ 57.77M | $ 45.43M | $ -35.10M | $ -96.72M |
| Total Liabilities | $ 101.29M | $ 114.19M | $ 117.41M | $ 93.21M | $ 101.14M |
| Stockholders' Equity | $ 32.44M | $ 80.58M | $ 124.48M | $ 162.40M | $ 167.81M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.57M | $ -14.96M | $ -49.20M | $ -25.13M | $ 90.82M |
| Operating Cash Flow | $ -5.89M | $ -10.12M | $ -9.65M | $ 4.95M | $ 109.83M |
| Investing Cash Flow | $ 3.04M | $ -4.60M | $ -54.81M | $ -39.08M | $ -28.96M |
| Financing Cash Flow | $ 6.91M | $ -801.00K | $ 5.17M | $ -10.81M | $ 14.40M |
Currency in EUR